At Safe Harbor Group, our experts are dedicated to providing invaluable insights that help healthcare providers navigate complex regulatory environments with confidence. Our deep knowledge and experience empower you to make informed decisions that protect your practice from compliance risks and ensure long-term success.
FDA’s Overreach on Compounded Peptides: Legal Battles and How Clinics Can Push Back
Introduction: Peptide therapies like BPC-157, TB-500 (Thymosin Beta-4), CJC-1295, and other short proteins have exploded…
WOUND CARE UPDATE: CY 2026 Medicare Physician Fee Schedule Final Rule (CMS1832F)
Published November 5, 2025 • Effective January 1, 2026 This update explains the new Medicare…
CMS Withdraws Final Skin Substitute LCDs; 2026 Oversight and Payment Reforms Remain the Operative Risk Environment
CMS has announced that its A/B Medicare Administrative Contractors (MACs) have withdrawn, effective immediately, the…
Charges Dismissed Against Whistleblower Physician — A Victory for Transparency and a Reminder on HIPAA Compliance
The U.S. Department of Justice (DOJ) dismissed all charges against Dr. Eithan Haim, who blew…
Chapman Predicts Stark Infested Waters For 2025
By Ronald W. Chapman II As a lawyer who has defended healthcare professionals across the…
Advanced Wound Care Products, Big Medicare Dollars & The Kickback Trap
From audits resulting in significant overpayment demands to indictments for alleged violations of the Anti-Kickback…
FDA’s “Held for Sale” Interpretation: Device Reuse in Physician Offices and FDCA Liability
Practicing and hospital-based physicians may be surprised to learn that the Federal Food, Drug, and…
False Claims Act Statistical Sampling & Extrapolation: Case Law and Guidance
Statistical sampling and extrapolation are methods used by the Office of Inspector General (OIG) and…
DEA’s Proposed Telemedicine Rules: What Doctors Need to Know (and Why It Might Get Complicated)
By Ronald W. Chapman II, Safe Harbor Group The Drug Enforcement Administration (DEA) has been working…
SHG President & Founder Discusses Red Flags and Healthcare Compliance
SHG Healthcare President Ronald Chapman II discusses DEA Red Flags and compliance investigations for healthcare providers with Mark…
SHG Founder Discusses Regulatory Enforcement Trends
SHG Healthcare President Ronald Chapman II discusses healthcare regulatory enforcement trends on a recent episode of the Compliance Perspectives…
Legal Preparedness in Healthcare: Drug Diversion Insights Podcast
Safe Harbor Group President Ronald Chapman II was featured on the Drug Diversion Insights podcast hosted by Terri…
Compliance & Healthcare Fraud: The Pain Unfiltered Podcast
SHG Healthcare President Ronald Chapman II was featured on the Pain Unfiltered Podcast, hosted by the American Society…
SHG Founder Discusses Federal Investigations
https://youtu.be/ZUoE5G2X2vM SHG Healthcare President Ronald Chapman II appears on White Collar Advice SHG Healthcare President Ronald…
SHG Founder on Becker’s Healthcare Podcast to Discuss Healthcare Fraud Investigations
SHG Founder Ronald Chapman II, Esq., LLM, sits down with Becker’s Healthcare Podcast to discuss…
SHG Founder Discusses Physician Requirements for Legal Preparedness
SHG Healthcare President Ronald Chapman II recently appeared on The Podcast by Kevin MD to discuss healthcare compliance….
SHG Founder Discusses Healthcare Law
SHG Healthcare President Ronald Chapman II appears on Healthcare Unfiltered SHG Healthcare President Ronald Chapman II discusses healthcare…
SHG Founder Doctor Patient Forum Interview
SHG Founder, Ronald W. Chapman II sits down with Claudia Merandi of the Doctor Patient…
WOUND CARE UPDATE: CY 2026 Medicare Physician Fee Schedule Final Rule (CMS1832F)
Published November 5, 2025 • Effective January 1, 2026 This update explains the new Medicare…
CMS Withdraws Final Skin Substitute LCDs; 2026 Oversight and Payment Reforms Remain the Operative Risk Environment
CMS has announced that its A/B Medicare Administrative Contractors (MACs) have withdrawn, effective immediately, the…
DEA’s Proposed Telemedicine Rules: What Doctors Need to Know (and Why It Might Get Complicated)
By Ronald W. Chapman II, Safe Harbor Group The Drug Enforcement Administration (DEA) has been working…
The McKinsey Case: A Wake-Up Call
McKinsey, one of the most prestigious consulting firms in the world, got tangled up in…
Breaking Down the Overrule of Chevron: What It Means for Healthcare Providers
Breaking Down the Overrule of Chevron: What It Means for Healthcare Providers November 11, 2024 Compliance…
DOJ Investigation into Done Global Inc.:Telemedicine Adderall Provider UnderScrutiny
Introduction Done Global Inc., is a prominent telehealth provider specializing in ADHD treatment. The company…
FDA’s Overreach on Compounded Peptides: Legal Battles and How Clinics Can Push Back
Introduction: Peptide therapies like BPC-157, TB-500 (Thymosin Beta-4), CJC-1295, and other short proteins have exploded…
WOUND CARE UPDATE: CY 2026 Medicare Physician Fee Schedule Final Rule (CMS1832F)
Published November 5, 2025 • Effective January 1, 2026 This update explains the new Medicare…
CMS Withdraws Final Skin Substitute LCDs; 2026 Oversight and Payment Reforms Remain the Operative Risk Environment
CMS has announced that its A/B Medicare Administrative Contractors (MACs) have withdrawn, effective immediately, the…
Charges Dismissed Against Whistleblower Physician — A Victory for Transparency and a Reminder on HIPAA Compliance
The U.S. Department of Justice (DOJ) dismissed all charges against Dr. Eithan Haim, who blew…
Chapman Predicts Stark Infested Waters For 2025
By Ronald W. Chapman II As a lawyer who has defended healthcare professionals across the…
Advanced Wound Care Products, Big Medicare Dollars & The Kickback Trap
From audits resulting in significant overpayment demands to indictments for alleged violations of the Anti-Kickback…
FDA’s “Held for Sale” Interpretation: Device Reuse in Physician Offices and FDCA Liability
Practicing and hospital-based physicians may be surprised to learn that the Federal Food, Drug, and…
False Claims Act Statistical Sampling & Extrapolation: Case Law and Guidance
Statistical sampling and extrapolation are methods used by the Office of Inspector General (OIG) and…
DEA’s Proposed Telemedicine Rules: What Doctors Need to Know (and Why It Might Get Complicated)
By Ronald W. Chapman II, Safe Harbor Group The Drug Enforcement Administration (DEA) has been working…
Top 10 Dirty Tricks Federal Investigators Use to Generate Evidence: A Deep Dive into Deception
Top 10 Dirty Tricks Federal Investigators Use to Generate Evidence: A Deep Dive into Deception Ron…
Why TikTok’s Survival Matters: The New Law That Threatens the 1st Amendment
The Protecting Americans from Foreign Adversary Controlled Applications Act (PFACAA) is a tyrannical law that…
Top DOJ Enforcement Risks for Small to Mid-Sized Businesses in 2025
Navigating the shifting regulatory landscape in 2025 can be daunting for small to mid-sized businesses….
DOGE Plan Released: The no-nonsense breakdown for business owners in Healthcare and Finance
Ron Chapman is a Federal Defense Attorney and Author of Unraveling Federal Criminal Investigations. He’s spent…
Breaking Down the Overrule of Chevron: What It Means for Healthcare Providers
Breaking Down the Overrule of Chevron: What It Means for Healthcare Providers November 11, 2024 Compliance…
Pharmacy Exclusions: When the Corporate Pharmacy is the Judge, Jury and the Executioner
Healthcare practitioners who prescribe controlled substances already face a litany of regulations and scrutiny from…
Making Sense of the Anti-Kickback Statute (AKS)
Intent and Purpose of the AKS The Anti-Kickback Statute (AKS) is fundamentally designed to safeguard…
Building a Culture of Healthcare Compliance: Step-by-Step Guidance
Elevating Healthcare Standards through Comprehensive Compliance Training and Best Practices In the intricate world of…
Wound Care Healthcare Fraud is On the Rise – What You Need to Know About Protecting Your Practice
As the U.S. Department of Justice continues to crack down on healthcare fraud, wound care…
How Local Coverage Determinations (LCDs) Should Be Handled as Evidence Under the Bondi Administration
The weight of Local Coverage Determinations (LCDs) in False Claims Act (FCA) litigation has been…
False Claims Act Statistical Sampling & Extrapolation: Case Law and Guidance
Statistical sampling and extrapolation are methods used by the Office of Inspector General (OIG) and…
FDA’s “Held for Sale” Interpretation: Device Reuse in Physician Offices and FDCA Liability
Practicing and hospital-based physicians may be surprised to learn that the Federal Food, Drug, and…
Advanced Wound Care Products, Big Medicare Dollars & The Kickback Trap
From audits resulting in significant overpayment demands to indictments for alleged violations of the Anti-Kickback…
